Table 1

Characteristics of the individual studies assessing BP after CoA stenting

First author, year	Sample size	Female (%)	Age (years)	Native CoA (%)	Recurrent CoA (%)	PSG baseline (mm Hg)	PSG post (mm Hg)	Duration of FU (months)
Agnoletti, 200511	15	NA	17	0	100	27	4	22
Bentham, 201310	40	28	25	50	50	25	3	52
Bondanza, 201622	34	29	11	68	32	41	2	120
Forbes, 20117	217	31	17	100	0	37	5	33
Grøndahl, 201723	9	22	34	0	100	14	2	21
Haji Zeinali, 201724	62	36	31	95	5	62	3	46
Hamdan, 200125	34	26	16	38	62	32	4	29
Harrison, 200126	27	44	30	74	26	46	3	22
Honing-Hemmers, 200327	33	33	21	33	67	37	7	21
Kische, 201528	52	44	37	100	0	55	3	48
Krasemann, 201129	68	38	26	60	40	25	5	41
Lam, 200730	21	48	34	62	38	43	12	14
Macdonald, 200331	15	NA	32	67	33	43	3	36
Mahadevan, 200632	37	41	31	65	35	28	4	12
Meadows, 201533	104	NA	NA	NA	NA	29	2	24
Moltzer, 201034	24	50	35	25	75	19	0	27
Musto, 200812	21	38	34	71	29	59	11	51
Pedra, 200535	21	33	24	100	0	47	0	22
Sadiq, 201336	56	31	22	100	0	51	5	46
Sohrabi, 201437	120	33	24	100	0	55	3	31
Tanous, 201038	22	50	39	64	36	29	3	12
Tyagi, 200339	21	24	29	100	0	68	8	41
Tzifa, 200640	30	NA	28	47	53	36	4	12
van der Burg, 201841	43	40	41	60	40	28	3	20
Yeaw, 201642	9	22	40	100	0	42	NA	14
Zabal, 200343	22	36	26	100	0	64	3	22
Median (range)	32(9–217)	35 (22–50)	29 (11–41)	67 (0–100)	33 (0–100)	39 (14–68)	3 (0–12)	26 (12–120)

Individual study data are presented as percentages for dichotomous variables and mean or median (according to the description provided by the study) for continuous variables. Across-study distributions are expressed as median and range.
BP, blood pressure; CoA, coarctation of the aorta; FU, follow-up; NA, not available; PSG, peak systolic gradient across CoA site.